IONS
IONS
NASDAQ · Biotechnology

Ionis Pharmaceuticals Inc

$75.71
-0.31 (-0.41%)
As of May 9, 1:07 AM ET ·
Analyst Consensus
Strong Buy
29
Analysts
High
Coverage
Buy 22 76%
Hold 7 24%
Sell 0 0%
Price Target
Analyst Price Target -1.0% upside
Low Target $58.43
Average Target $74.94
High Target $113.95
Current Price $75.71
Current
$75.71
Target
$74.94
$58.43 $74.94 avg $113.95
Scenario Analysis
Bear Case
$58.43
-22.8%
Low target
Base Case
$74.94
-1.0%
Avg target
Bull Case
$113.95
+50.5%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$86.74
-12.7% from high
52-Week Low
$31.66
+139.1% from low
50-Day SMA
$80.92
-6.4% vs SMA
200-Day SMA
$60.03
+26.1% vs SMA
RSI (14)
47.8
Neutral
Target vs 52W High
$74.94
-13.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
Strong Buy 26 96% $143.40 +41.5%